UNIQ Trials
PK/PD & ModelingBioanalytical ServicesIND / Regulatory Package AuthoringOncologyHematologySmall MoleculePeptide
Quick answer
Outsourcing a cell therapy (CAR-T, NK, or TIL) program means contracting specialists for vector supply, process and analytical development, GMP autologous or allogeneic manufacturing, potency and release testing, and regulatory CMC support. BioBridgeX is the neutral marketplace: free for buyers, where you compare quotes and contract directly with every supplier you engage, in one place.
Cell Therapy (CAR-T / NK / TIL) CRO and CDMO vendors (84)
TRiCBIO
Target ID & ValidationAssay Development & ScreeningHit IdentificationOncologyCNS / NeurologySmall MoleculePeptide
VCHP Clinical Solutions
Computational / AI-Driven DiscoveryPK/PD & ModelingPhase 1 / Early Clinical UnitOncologyHematologySmall MoleculePeptide
Symbiosis Pharmaceutical Services
Unclaimed · public records
CDMO · Aseptic Fill-Finish, Drug Product Manufacturing, QC & Release Testing
Aseptic Fill-FinishDrug Product ManufacturingQC & Release TestingOncologyRare / Orphan DiseaseMonoclonal Antibody (mAb)Antibody-Drug Conjugate (ADC)
Merck KGaA (MilliporeSigma / Sigma-Aldrich CTDMO)
Unclaimed · public records
CRO & CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, mRNA / RNA Manufacturing
Viral Vector ManufacturingCell Therapy ManufacturingmRNA / RNA ManufacturingOncologyHematologyGene Therapy (AAV / Viral Vector)Cell Therapy (CAR-T / NK / TIL)
VectorBuilder
Unclaimed · public records
CRO & CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Viral Vector ManufacturingPlasmid DNA ManufacturingProcess DevelopmentOncologyRare / Orphan DiseaseGene Therapy (AAV / Viral Vector)Plasmid DNA
Pharmaron (Biologics / CGT)
Unclaimed · public records
CRO & CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
Viral Vector ManufacturingPlasmid DNA ManufacturingCell Therapy ManufacturingOncologyRare / Orphan DiseaseGene Therapy (AAV / Viral Vector)Plasmid DNA
Esco Aster
Unclaimed · public records
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
Viral Vector ManufacturingPlasmid DNA ManufacturingCell Therapy ManufacturingOncologyInfectious DiseaseGene Therapy (AAV / Viral Vector)Plasmid DNA
3PBIOVIAN (3P Biopharmaceuticals + Biovian)
Unclaimed · public records
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
Viral Vector ManufacturingPlasmid DNA ManufacturingCell Therapy ManufacturingOncologyRare / Orphan DiseaseGene Therapy (AAV / Viral Vector)Plasmid DNA
SK pharmteco
Unclaimed · public records
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
Viral Vector ManufacturingPlasmid DNA ManufacturingCell Therapy ManufacturingOncologyHematologyGene Therapy (AAV / Viral Vector)Cell Therapy (CAR-T / NK / TIL)
The Center for Breakthrough Medicines
Unclaimed · public records
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Viral Vector ManufacturingCell Therapy ManufacturingPlasmid DNA ManufacturingOncologyHematologyGene Therapy (AAV / Viral Vector)Cell Therapy (CAR-T / NK / TIL)
ElevateBio BaseCamp
Unclaimed · public records
CDMO · Cell Therapy Manufacturing, Viral Vector Manufacturing, Process Development
Cell Therapy ManufacturingViral Vector ManufacturingProcess DevelopmentOncologyHematologyCell Therapy (CAR-T / NK / TIL)Gene Therapy (AAV / Viral Vector)
RoslinCT
Unclaimed · public records
CDMO · Cell Therapy Manufacturing, Process Development, Analytical Development
Cell Therapy ManufacturingProcess DevelopmentAnalytical DevelopmentHematologyOncologyCell Therapy (CAR-T / NK / TIL)Gene Editing (CRISPR-based)
Minaris Advanced Therapies
Unclaimed · public records
CDMO · Cell Therapy Manufacturing, Viral Vector Manufacturing, Process Development
Cell Therapy ManufacturingViral Vector ManufacturingProcess DevelopmentOncologyHematologyCell Therapy (CAR-T / NK / TIL)Gene Therapy (AAV / Viral Vector)
Cellipont Bioservices
Unclaimed · public records
CDMO · Cell Therapy Manufacturing, Process Development, Analytical Development
Cell Therapy ManufacturingProcess DevelopmentAnalytical DevelopmentOncologyHematologyCell Therapy (CAR-T / NK / TIL)
Genezen
Unclaimed · public records
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Viral Vector ManufacturingCell Therapy ManufacturingPlasmid DNA ManufacturingOncologyHematologyGene Therapy (AAV / Viral Vector)Cell Therapy (CAR-T / NK / TIL)
National Resilience
Unclaimed · public records
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, mRNA / RNA Manufacturing
Viral Vector ManufacturingCell Therapy ManufacturingmRNA / RNA ManufacturingOncologyHematologyGene Therapy (AAV / Viral Vector)Cell Therapy (CAR-T / NK / TIL)
FUJIFILM Biotechnologies (formerly FUJIFILM Diosynth)
Unclaimed · public records
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Process Development
Viral Vector ManufacturingCell Therapy ManufacturingProcess DevelopmentOncologyRare / Orphan DiseaseGene Therapy (AAV / Viral Vector)Cell Therapy (CAR-T / NK / TIL)
Oxford Biomedica
Unclaimed · public records
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Viral Vector ManufacturingPlasmid DNA ManufacturingProcess DevelopmentOncologyHematologyGene Therapy (AAV / Viral Vector)Cell Therapy (CAR-T / NK / TIL)
WuXi Advanced Therapies
Unclaimed · public records
CRO & CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Viral Vector ManufacturingCell Therapy ManufacturingPlasmid DNA ManufacturingOncologyHematologyGene Therapy (AAV / Viral Vector)Cell Therapy (CAR-T / NK / TIL)
Catalent
Unclaimed · public records
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Viral Vector ManufacturingCell Therapy ManufacturingPlasmid DNA ManufacturingOncologyHematologyGene Therapy (AAV / Viral Vector)Cell Therapy (CAR-T / NK / TIL)
GenScript ProBio
Unclaimed · public records
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Cell Line / Strain DevelopmentProcess DevelopmentAnalytical DevelopmentOncologyImmunology & InflammationMonoclonal Antibody (mAb)Bispecific / Multispecific Antibody
3PBIOVIAN
Unclaimed · public records
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Cell Line / Strain DevelopmentProcess DevelopmentAnalytical DevelopmentOncologyImmunology & InflammationMonoclonal Antibody (mAb)Protein / Enzyme (Recombinant)
AGC Biologics
Unclaimed · public records
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Cell Line / Strain DevelopmentProcess DevelopmentAnalytical DevelopmentOncologyImmunology & InflammationMonoclonal Antibody (mAb)Bispecific / Multispecific Antibody
Catalent Biologics
Unclaimed · public records
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Cell Line / Strain DevelopmentProcess DevelopmentAnalytical DevelopmentOncologyImmunology & InflammationMonoclonal Antibody (mAb)Bispecific / Multispecific Antibody
Thermo Fisher Scientific (Patheon)
Unclaimed · public records
CRO & CDMO · Process Development, Drug Substance: Small Molecule / API, Analytical Development
Process DevelopmentDrug Substance: Small Molecule / APIAnalytical DevelopmentOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
Lonza
Unclaimed · public records
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Drug Substance: Small Molecule / APIProcess DevelopmentAnalytical DevelopmentOncologyRare / Orphan DiseaseSmall MoleculeAntibody-Drug Conjugate (ADC)
Eurofins (Pharma Discovery & Bioanalytical Services)
Unclaimed · public records
CRO & CDMO · Bioanalytical Services, Central Laboratory Services, Genetic Toxicology
Bioanalytical ServicesCentral Laboratory ServicesGenetic ToxicologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
QPS Holdings
Unclaimed · public records
CRO · Bioanalytical Services, DMPK / ADME, GLP Toxicology
Bioanalytical ServicesDMPK / ADMEGLP ToxicologyCNS / NeurologyOncologySmall MoleculeMonoclonal Antibody (mAb)
NorthEast BioLab
Unclaimed · public records
CRO · Bioanalytical Services, Immunogenicity & Immunotoxicology, Biomarker Discovery & Development
Bioanalytical ServicesImmunogenicity & ImmunotoxicologyBiomarker Discovery & DevelopmentOncologyImmunology & InflammationSmall MoleculeMonoclonal Antibody (mAb)
Synexa Life Sciences
Unclaimed · public records
CRO · Biomarker Discovery & Development, Bioanalytical Services, Immunogenicity & Immunotoxicology
Biomarker Discovery & DevelopmentBioanalytical ServicesImmunogenicity & ImmunotoxicologyOncologyImmunology & InflammationMonoclonal Antibody (mAb)Protein / Enzyme (Recombinant)
CellCarta
Unclaimed · public records
CRO · Biomarker Discovery & Development, Bioanalytical Services, Immunogenicity & Immunotoxicology
Biomarker Discovery & DevelopmentBioanalytical ServicesImmunogenicity & ImmunotoxicologyOncologyImmunology & InflammationMonoclonal Antibody (mAb)Protein / Enzyme (Recombinant)
Certara
Unclaimed · public records
CRO · PK/PD & Modeling, Biostatistics & Statistical Programming, Medical Writing
PK/PD & ModelingBiostatistics & Statistical ProgrammingMedical WritingOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
LabConnect
Unclaimed · public records
CRO · Central Laboratory Services, Biomarker Discovery & Development, Clinical Data Management
Central Laboratory ServicesBiomarker Discovery & DevelopmentClinical Data ManagementOncologyImmunology & InflammationSmall MoleculeMonoclonal Antibody (mAb)
Labcorp
Unclaimed · public records
CRO & CDMO · Central Laboratory Services, GLP Toxicology, Safety Pharmacology
Central Laboratory ServicesGLP ToxicologySafety PharmacologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
Q2 Solutions
Unclaimed · public records
CRO · Central Laboratory Services, Biomarker Discovery & Development, Bioanalytical Services
Central Laboratory ServicesBiomarker Discovery & DevelopmentBioanalytical ServicesOncologyImmunology & InflammationSmall MoleculeMonoclonal Antibody (mAb)
BioAgilytix Labs
Unclaimed · public records
CRO · Bioanalytical Services, Immunogenicity & Immunotoxicology, Biomarker Discovery & Development
Bioanalytical ServicesImmunogenicity & ImmunotoxicologyBiomarker Discovery & DevelopmentOncologyImmunology & InflammationMonoclonal Antibody (mAb)Protein / Enzyme (Recombinant)
TD2 (Translational Drug Development)
Unclaimed · public records
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, PK/PD & Modeling
In Vitro PharmacologyBiomarker Discovery & DevelopmentPK/PD & ModelingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
InnoSer Laboratories
Unclaimed · public records
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, PK/PD & Modeling
In Vitro PharmacologyBiomarker Discovery & DevelopmentPK/PD & ModelingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Noble Life Sciences
Unclaimed · public records
CRO · In Vitro Pharmacology, GLP Toxicology, Bioanalytical Services
In Vitro PharmacologyGLP ToxicologyBioanalytical ServicesOncologyInfectious DiseaseSmall MoleculeMonoclonal Antibody (mAb)
GemPharmatech
Unclaimed · public records
CRO · In Vitro Pharmacology, Target ID & Validation, Biomarker Discovery & Development
In Vitro PharmacologyTarget ID & ValidationBiomarker Discovery & DevelopmentOncologyMetabolic / EndocrinologySmall MoleculeMonoclonal Antibody (mAb)
Biocytogen
Unclaimed · public records
CRO · In Vitro Pharmacology, Target ID & Validation, Biomarker Discovery & Development
In Vitro PharmacologyTarget ID & ValidationBiomarker Discovery & DevelopmentOncologyHematologyMonoclonal Antibody (mAb)Bispecific / Multispecific Antibody
EPO Berlin-Buch (Experimental Pharmacology & Oncology)
Unclaimed · public records
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, PK/PD & Modeling
In Vitro PharmacologyBiomarker Discovery & DevelopmentPK/PD & ModelingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Labcorp (Labcorp Drug Development)
Unclaimed · public records
CRO · In Vitro Pharmacology, DMPK / ADME, GLP Toxicology
In Vitro PharmacologyDMPK / ADMEGLP ToxicologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
WuXi AppTec (WuXi Biology)
Unclaimed · public records
CRO & CDMO · In Vitro Pharmacology, DMPK / ADME, Bioanalytical Services
In Vitro PharmacologyDMPK / ADMEBioanalytical ServicesOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
The Jackson Laboratory (JAX)
Unclaimed · public records
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, Target ID & Validation
In Vitro PharmacologyBiomarker Discovery & DevelopmentTarget ID & ValidationOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
GenScript
Unclaimed · public records
CRO & CDMO · Assay Development & Screening, Protein Sciences & Reagents, Medicinal & Synthetic Chemistry
Assay Development & ScreeningProtein Sciences & ReagentsMedicinal & Synthetic ChemistryOncologyImmunology & InflammationMonoclonal Antibody (mAb)Protein / Enzyme (Recombinant)
JOINN Laboratories / Biomere
Unclaimed · public records
CRO · GLP Toxicology, Safety Pharmacology, Toxicokinetics (TK)
GLP ToxicologySafety PharmacologyToxicokinetics (TK)OncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
KCAS Bio
Unclaimed · public records
CRO · Bioanalytical Services, Biomarker Discovery & Development, Immunogenicity & Immunotoxicology
Bioanalytical ServicesBiomarker Discovery & DevelopmentImmunogenicity & ImmunotoxicologyOncologyCardiovascularSmall MoleculeMonoclonal Antibody (mAb)
IQVIA Laboratories (Q2 Solutions)
Unclaimed · public records
CRO · Bioanalytical Services, Biomarker Discovery & Development, DMPK / ADME
Bioanalytical ServicesBiomarker Discovery & DevelopmentDMPK / ADMEOncologyImmunology & InflammationSmall MoleculeMonoclonal Antibody (mAb)
BioAgilytix
Unclaimed · public records
CRO · Bioanalytical Services, Immunogenicity & Immunotoxicology, Biomarker Discovery & Development
Bioanalytical ServicesImmunogenicity & ImmunotoxicologyBiomarker Discovery & DevelopmentOncologyImmunology & InflammationMonoclonal Antibody (mAb)Bispecific / Multispecific Antibody
Evotec
Unclaimed · public records
CRO & CDMO · In Vitro / Early Toxicology, DMPK / ADME, Safety Pharmacology
In Vitro / Early ToxicologyDMPK / ADMESafety PharmacologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
Champions Oncology
Unclaimed · public records
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, Assay Development & Screening
In Vitro PharmacologyBiomarker Discovery & DevelopmentAssay Development & ScreeningOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Crown Bioscience
Unclaimed · public records
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, Assay Development & Screening
In Vitro PharmacologyBiomarker Discovery & DevelopmentAssay Development & ScreeningOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
WuXi AppTec
Unclaimed · public records
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
GLP ToxicologySafety PharmacologyGenetic ToxicologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
Inotiv
Unclaimed · public records
CRO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
GLP ToxicologySafety PharmacologyGenetic ToxicologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
Labcorp (Labcorp Drug Development / former Covance)
Unclaimed · public records
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
GLP ToxicologySafety PharmacologyGenetic ToxicologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
Charles River Laboratories
Unclaimed · public records
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
GLP ToxicologySafety PharmacologyGenetic ToxicologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
Avance Clinical
Unclaimed · public records
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Clinical OperationsPhase 1 / Early Clinical UnitClinical Data ManagementOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
TFS HealthScience
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Cytel
Unclaimed · public records
CRO · Biostatistics & Statistical Programming, Clinical Data Management, Clinical Operations
Biostatistics & Statistical ProgrammingClinical Data ManagementClinical OperationsOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Precision for Medicine
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Pharmaron
Unclaimed · public records
CRO & CDMO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
WuXi Clinical
Unclaimed · public records
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Clinical OperationsPhase 1 / Early Clinical UnitClinical Data ManagementOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Tigermed
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
CMIC Group
Unclaimed · public records
CRO & CDMO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
Linical
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
ClinChoice
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
Emmes
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
ProPharma
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)
Novotech
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Premier Research
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Veristat
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Caidya
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Allucent
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
PSI CRO
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Worldwide Clinical Trials
Unclaimed · public records
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Clinical OperationsPhase 1 / Early Clinical UnitClinical Data ManagementOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Syneos Health
Unclaimed · public records
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Clinical OperationsPhase 1 / Early Clinical UnitClinical Data ManagementOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Medpace
Unclaimed · public records
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Clinical OperationsPhase 1 / Early Clinical UnitClinical Data ManagementOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Fortrea
Unclaimed · public records
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Clinical OperationsPhase 1 / Early Clinical UnitClinical Data ManagementOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
PPD (Thermo Fisher Scientific)
Unclaimed · public records
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Clinical OperationsPhase 1 / Early Clinical UnitClinical Data ManagementOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
Parexel
Unclaimed · public records
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Clinical OperationsPhase 1 / Early Clinical UnitClinical Data ManagementOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
ICON plc
Unclaimed · public records
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Clinical OperationsPhase 1 / Early Clinical UnitClinical Data ManagementOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
IQVIA
Unclaimed · public records
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Clinical OperationsClinical Data ManagementBiostatistics & Statistical ProgrammingOncologyHematologySmall MoleculeMonoclonal Antibody (mAb)
What does it take to develop and manufacture a Cell Therapy (CAR-T / NK / TIL) drug?
Cell therapy is the hardest CMC problem in the modality landscape, and the work spreads across more suppliers than most teams expect at the outset. On the discovery and preclinical side you are validating a construct (the CAR design, the costimulatory domains, the cell source), running in vitro potency and cytotoxicity assays, and pushing toward IND-enabling tox in a relevant model. Cell products do not behave like small molecules in tox studies, so you often need a CRO that has actually run studies on a living cell drug rather than one that treats it as another biologic.
The center of gravity, though, is manufacturing. An autologous CAR-T process starts from a patient apheresis, runs through activation, viral transduction, expansion, formulation, and cryopreservation, and every one of those steps has to be locked down, characterized, and made reproducible across operators and sites. Allogeneic NK and TIL programs change the math: you are building a scalable, donor-derived or expanded process where consistency across a much larger batch matters more than turnaround on a single patient. Either way you need vector. Most CAR-T and many gene-modified NK programs depend on a lentiviral or retroviral vector, which means a viral vector manufacturing slot (and the plasmid DNA upstream of it) is on your critical path long before you reach clinical supply.
This is where specialist CDMOs separate from generalists. A generalist biologics shop can run a bioreactor and fill vials; far fewer have validated, GMP-grade closed-system cell processing, cryo logistics, a chain-of-identity and chain-of-custody system tying a product back to the right patient, and the potency and flow-based release panels regulators now expect for a cell drug. Analytical capability is the quiet differentiator: vector copy number, transduction efficiency, viability, identity, sterility, mycoplasma, endotoxin, and a potency assay that actually predicts clinical activity. A supplier that has filed this package before, and survived the agency questions that come with it, saves you months you cannot get back.
How do you choose a CRO or CDMO for Cell Therapy (CAR-T / NK / TIL)?
Supplier selection for cell therapy rewards specificity. The right partner for an autologous CAR-T is often the wrong one for an allogeneic NK platform, so screen against your exact process, scale, and regulatory path rather than a generic capability list. Use the checklist below as a starting screen, then go deep with the two or three suppliers that survive it.
- Relevant platform and track record: have they run your specific format (autologous CAR-T, allogeneic NK, TIL) through process development and GMP, not just adjacent gene therapy work? Ask for the cell types and constructs they have actually handled.
- GxP and analytical capability for this modality: validated GMP cleanrooms or closed/isolator systems, plus an analytical team that owns vector copy number, transduction efficiency, viability, identity, sterility, mycoplasma, and a real potency assay, not outsourced piecemeal.
- Vector and starting-material supply: in-house or reliably sourced lentiviral or retroviral vector and plasmid DNA, with timeline and slot availability that fits your clinical schedule, since vector lead times often dominate the program.
- Capacity and scale: enough suites and cryo capacity to run your batch cadence today and a credible path to commercial scale, whether that is many small autologous runs or fewer large allogeneic lots.
- Regulatory experience: prior INDs, BLAs, or comparable filings for cell products, familiarity with FDA and EMA expectations for potency and comparability, and the ability to author or support the CMC sections rather than hand you raw data.
- Chain of identity and logistics: a documented chain-of-identity and chain-of-custody system, cryopreservation and cold-chain handling, and apheresis or starting-material coordination that will not break under clinical timelines.
- IP and data ownership: clear terms that your process know-how, cell lines, and analytical methods remain yours, with no claim on your construct or downstream rights.
Frequently asked questions
Do I need separate suppliers for vector and cell manufacturing, or can one CDMO do both?
Some larger cell therapy CDMOs offer both viral vector and drug-product manufacturing under one roof, which simplifies tech transfer and comparability. Many programs still split them, sourcing lentiviral or retroviral vector from a dedicated vector house and running cell processing elsewhere. Both models work. The split adds an interface to manage but widens your options on capacity and price. On BioBridgeX you can engage a single integrated CDMO or a vector supplier plus a separate manufacturer and still compare quotes and contract directly with each chosen supplier in one place.
What is the difference between sourcing for an autologous CAR-T versus an allogeneic NK or TIL program?
Autologous is a one-patient, one-batch problem: turnaround time, chain of identity, and apheresis logistics dominate, and you need many short reproducible runs. Allogeneic NK and TIL programs are a scale and consistency problem: larger donor-derived or expanded lots, banking, and batch-to-batch comparability matter more than single-run speed. A CDMO strong in one is not automatically strong in the other, so screen suppliers against your specific format rather than a generic cell therapy label.
How early should I lock in a cell therapy manufacturing slot?
Earlier than feels comfortable. GMP cell therapy and viral vector capacity is genuinely constrained, and vector lead times alone can run many months. Teams that wait until process development is finished often find the slot they wanted is booked, which pushes the whole clinical timeline. A practical pattern is to start supplier conversations during late preclinical, secure vector and a manufacturing slot in parallel, and treat capacity as a critical-path item rather than a procurement afterthought.
Who owns my construct, process, and data when I outsource to a CDMO?
Your construct, cell lines, process know-how, and analytical methods should remain entirely yours. A well-structured agreement gives the CDMO a license to perform the work and nothing more, with no claim on your IP or downstream rights. Cell therapy contracts get complicated because process and product blur together, so read the background-IP and improvements clauses carefully. BioBridgeX contracts are written so the buyer keeps ownership of study data and IP by default.
Is BioBridgeX really free for buyers, and how does the pricing work?
Yes. Buyers pay no platform fee to source, compare, or contract through BioBridgeX. We act as the neutral marketplace and charge a flat 2 percent fee to the supplier, deducted before disbursement, so it does not sit on top of your quote. You see supplier pricing directly and compare quotes, then contract directly with each chosen supplier in one place.
Can I run my whole cell therapy program, from preclinical CRO work through GMP supply, on one platform?
Yes. BioBridgeX covers the full path: discovery and preclinical CROs, IND-enabling toxicology, viral vector and plasmid DNA manufacturing, GMP cell therapy manufacturing, and analytical and release testing, across all indications and modalities. You can mix specialist suppliers for each step and still compare quotes and contract directly with each chosen supplier in one place, and the buyer pays the supplier directly.
Source Cell Therapy (CAR-T / NK / TIL) work with one contract
Compare transparent quotes from qualified Cell Therapy (CAR-T / NK / TIL) CRO and CDMO vendors, then contract once. Free for buyers.
Compare quotes